| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/23/2008 | CN101109012A Representation of vampire plasmin activator alpha 2 in yeast and manufacturing method thereof |
| 01/23/2008 | CN101108882A Fusion protein of HIV regulatory/accessory proteins |
| 01/23/2008 | CN101108879A Method for extracting active ingredient of natural leech essence |
| 01/23/2008 | CN101108878A Glp-1 analogues |
| 01/23/2008 | CN101108877A Nucleic acids and proteins from streptococcus pneumoniae |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN101108874A Method of preparing apolipoprotein A-I |
| 01/23/2008 | CN100363500C Preparation method of recombination human granular cell colony stimulating factor |
| 01/23/2008 | CN100363387C Mumia protein and its production process |
| 01/23/2008 | CN100363386C Truncation type zona pellucida protein of pig ova and its expression method |
| 01/23/2008 | CN100363385C Synthesis method of 3 beta protein of pig ovum pellucid zone |
| 01/23/2008 | CN100363384C Grass planted ganoderma polysaccharide peptide and its extraction method |
| 01/23/2008 | CN100363381C Method for extracting purified high ferro myoglobins from cardiac muscle |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/22/2008 | US7321089 Inbred corn line PHDRW |
| 01/22/2008 | US7321077 Repressor-mediated regulation system for control of gene expression in plants |
| 01/22/2008 | US7321028 Comprises leucine rich repeat domains; kits; drug screening; for treating apoptosis |
| 01/22/2008 | US7321024 Produced by a Paenibacillus polymyxa strain, used for reducing the levels of colonization by a target bacteria in animals, especially poultry. |
| 01/22/2008 | US7321023 SP16 protein |
| 01/22/2008 | US7320962 Hemoactive compositions and methods for their manufacture and use |
| 01/22/2008 | US7320959 Transgenic aniomal nmodels; screening; administering peptide |
| 01/22/2008 | US7320958 Insecticides; for controlling an insect population, such as Colorado potato beetle, southern corn rootworm and western corn rootworm, and for conferring to a plant resistance to a target insect species |
| 01/22/2008 | US7320892 Nucleotide sequences involved in plant disease resistance |
| 01/22/2008 | US7320890 Soluble steroidal peptides for nucleic acid delivery |
| 01/22/2008 | US7320888 Submergence-induced protein-like factors |
| 01/22/2008 | US7320880 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 01/22/2008 | US7320875 Screening for neutralizing hepatitis C virus antibodies in a blood sample utilizing an HCV E2 protein and a protein from a human or chimpanzee cell that has a molecular weight of 24 kd that binds to the E2 protein of HCV; comparing the amount of bound proteins to that in the absence of HCV antibodies |
| 01/22/2008 | US7320873 for diagnosing autoimmune disease (rheumatoid arthritis) activity using monoclonal antibodies |
| 01/22/2008 | US7320871 Human prostaglandin FP receptor variants and methods of using same |
| 01/22/2008 | US7320870 Identifying a nucleic acid sequence encoding a lacritin receptor by contacting transfected cells with lacritin and detecting calcium signaling |
| 01/22/2008 | US7320869 Antibodies to Chemokine Alpha-5 |
| 01/22/2008 | US7320868 Leptin binding domain compositions and methods thereto |
| 01/22/2008 | US7320863 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/22/2008 | US7320859 Using nucleoprotein filament complexes to transfer nucleotide sequences into cells; nonviral gene therapy |
| 01/22/2008 | US7320857 Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof |
| 01/22/2008 | US7320796 Nucleic acid bonding to tumor necrosis factor; genetic engineering; culture product |
| 01/22/2008 | US7320795 Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof |
| 01/22/2008 | US7320794 Membrane permeability of a substrate, hydantoin-transporter activity |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | US7320787 Genetic engineering; desroying infections; antitumor, anticancer agents |
| 01/22/2008 | CA2436779C Human mitochondrial proteins and polynucleotides encoding the proteins |
| 01/22/2008 | CA2380569C Chimeric polypeptides, method for production and uses thereof |
| 01/22/2008 | CA2289914C Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof |
| 01/22/2008 | CA2276491C Early detection of mycobacterial disease |
| 01/22/2008 | CA2215520C Chlamydia vaccines |
| 01/22/2008 | CA2191482C Transgenic plants with altered senescence characteristics |
| 01/17/2008 | WO2008008862A2 Proteome standards for mass spectrometry |
| 01/17/2008 | WO2008008805A2 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for non-clostridial toxin target cells |
| 01/17/2008 | WO2008008803A2 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells |
| 01/17/2008 | WO2008008047A1 Molecular probe for sphingolipids |
| 01/17/2008 | WO2008007960A2 Gainac specific binding molecules and uses thereof |
| 01/17/2008 | WO2008007941A1 Gainac specific binding molecules and uses thereof |
| 01/17/2008 | WO2008007818A1 Novel use of aimp1 for controlling glucose level |
| 01/17/2008 | WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient |
| 01/17/2008 | WO2008006893A1 Muteins of hngf, therapeutic uses and pharmaceutical compositions |
| 01/17/2008 | WO2008006850A2 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr |
| 01/17/2008 | WO2008006680A2 Method for producing l-amino acids by means of mutants of the glta gene coding for citrate synthase |
| 01/17/2008 | WO2008006497A1 Method for producing insulin analogs having a dibasic b chain terminus |
| 01/17/2008 | WO2008006496A1 Amidated glargine insulin |
| 01/17/2008 | WO2008006467A1 Antimicrobial peptide derived from galanin message associated peptide (gmap) |
| 01/17/2008 | WO2008006458A2 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 01/17/2008 | WO2008006189A1 Mimotope receptors and inhibitors for platelet- platelet and platelet-endothelium interactions |
| 01/17/2008 | WO2008006169A1 Polynucleotides and methods for enhancing salinity tolerance in plants |
| 01/17/2008 | WO2007136837A9 Prostate epithelial androgen receptor suppresses prostate growth and tumor invasion |
| 01/17/2008 | WO2007131778A8 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith |
| 01/17/2008 | WO2007131017A3 A METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (hCG) VACCINE FOR LONG-ACTING ANTIBODY PRODUCTION |
| 01/17/2008 | WO2007124283A3 Tetramerizing polypeptides and methods of use |
| 01/17/2008 | WO2007120834A3 Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability |
| 01/17/2008 | WO2007117762A9 Truncated il-17ra soluble receptor and methods of using in inflammation |
| 01/17/2008 | WO2007105350A3 Catalase gene and use thereof |
| 01/17/2008 | WO2007098420A3 Peptides that block the binding of igg to fcrn |
| 01/17/2008 | WO2007094867A3 Cell-based p38 mapk translocation assay |
| 01/17/2008 | WO2007079448A3 Three component carbohydrate vaccine |
| 01/17/2008 | WO2007062150A3 Leukotoxin compositions and therapeutic methods |
| 01/17/2008 | WO2007030708A3 Antimicrobial adzymes and uses thereof |
| 01/17/2008 | WO2007009018A3 Il-6 binding proteins |
| 01/17/2008 | WO2006105490A3 Compositions and methods for treating diseases associated with phlpp |
| 01/17/2008 | WO2005118786A3 Splice variants of peptide yy, neuropeptide y, pancreatic peptide y and amylin, and uses thereof |
| 01/17/2008 | WO2005021710A3 Chimeric molecules and methods of use |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | WO2004106935A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) |
| 01/17/2008 | WO2004072257A3 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | WO2002066670A3 46798, a human matrix metalloproteinase and uses therefor |
| 01/17/2008 | US20080016597 Peptide Transporting To Chromoplasts In Petals And Method Of Constructing Plant Having Yellowish Petals By Using The Same |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 01/17/2008 | US20080015339 High affinity fibronectin derivatives |
| 01/17/2008 | US20080015337 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 01/17/2008 | US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015151 Viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity, immunogenicity, improve pharmacokinetics, bioavailability; envelope viruses |
| 01/17/2008 | US20080015150 Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080015145 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| 01/17/2008 | US20080015144 Glp- (9-36) Methods and Compositions |
| 01/17/2008 | US20080015143 In Vitro Methods for Detecting Renal Cancer |
| 01/17/2008 | US20080015142 Glycopegylated Follicle Stimulating Hormone |
| 01/17/2008 | US20080015139 Soluble virus-specific T-cell receptor compositions |